1204005-98-0Relevant academic research and scientific papers
Synthesis and biological evaluation of triazol-4-ylphenyl-bearing histone deacetylase inhibitors as anticancer agents
He, Rong,Chen, Yufeng,Chen, Yihua,Ougolkov, Andrei V.,Zhang, Jin-San,Savoy, Doris N.,Billadeau, Daniel D.,Kozikowski, Alan P.
experimental part, p. 1347 - 1356 (2010/09/08)
Our triazole-based histone deacetylase inhibitor (HDACI), octanedioic acid hydroxyamide[3-(1-phenyl-1H-[1,2,3]triazol-4-yl)phenyl]amide (4a), suppresses pancreatic cancer cell growth in vitro with the lowest IC50 value of 20nM against MiaPaca-2
